Bare Metal Stents Market Analysis

Bare Metal Stents Market Analysis

To get key market trends

  Download Free Sample

Based on product, the bare metal stents market is segmented as self-expandable stent, and balloon expandable stent. In 2022, the balloon expandable stent segment accounted for the largest share of around 56% in market. One of the main advantages of balloon-expandable stents is its ability to be precisely sized and implanted at the desired location. These stents are placed on a balloon catheter and inflated within the vessel to the appropriate size. These precise dimensions and placement ensure that the stent completely covers the lesion (narrowing or blockage) and adapts to the vessel walls. In addition, balloon-expandable stents are frequently selected in conditions demanding precise stent insertion, such as coronary artery procedures.

Based on material type, the bare metal stents market is segmented as stainless-steel stents, cobalt-chromium alloy stents, and nitinol. The cobalt-chromium alloy stents segment accounted for the significant share of 50.9% in market. Cobalt-chromium alloys offer excellent radiopacity, making the stent highly visible under fluoroscopy and other medical imaging techniques. Enhanced visibility helps interventional cardiologists precisely position and deploy the stent within the target lesion. Moreover, it exhibits good flexibility and conformability, allowing them to navigate through tortuous anatomies and accommodate changes in vessel diameter.

 Based on application, the bare metal stents market is segmented as coronary artery disease, peripheral artery disease, and others. The coronary artery disease segment accounted for the largest share of 70.4% in market and is expected to record robust growth during the forecast period. Coronary artery disease is one of the most prevalent cardiovascular diseases globally. It affects millions of people, particularly in developed countries with lifestyle-related risk factors such as sedentary lifestyles, unhealthy diets, and smoking. The high prevalence of CAD leads to a substantial patient population in need of coronary interventions, including stent placement.

Based on end-use, the bare metal stents market is segmented as hospitals, ambulatory surgical centers, and others. The hospitals segment held a dominant business share of over 79% in 2022 and is expected to grow at a CAGR of 2.7% between 2023 to 2032. Hospitals are the primary healthcare institutions where coronary interventions, such as stent placements, are performed. Coronary artery disease (CAD) is a prevalent cardiovascular condition that requires medical attention, and hospitals are the primary facilities for diagnosing and treating patients with CAD. The high volume of coronary interventions conducted in hospitals creates a substantial demand for BMS.

North America bare metal stents market accounted for significant revenue in 2022 and is expected to reach over USD 112.4 million in 2032 with a CAGR of 1.6% from 2023-2032. North America boasts some of the most advanced healthcare infrastructure and facilities in the world. State-of-the-art hospitals, specialized cardiac centers, and a well-developed healthcare ecosystem make it a key region for the diagnosis and treatment of cardiovascular diseases.

Moreover, North America has among the highest healthcare spending globally. This significant investment in healthcare infrastructure, along with research, and development activities supports the adoption of advanced medical devices like BMS and ensures their widespread availability, leading to the regional expansion.